MedPath

CRYSVITA 30 MG SOLUCION INYECTABLE

CRYSVITA 30 MG SOLUCION INYECTABLE

Commercialized
Register Number

1171262003

Prescription Type

Uso Hospitalario

Authorization Date

May 11, 2018

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1171262003
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BUROSUMABActive
Quantity: 30 mg
Name: BUROSUMAB

ATC CLASSIFICATION (3)

M05B
M05BX
M05BX05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.